Data / Form D filings / Jaguar Health, Inc.
Jaguar Health, Inc.: Form D filings
Jaguar Health, Inc., a pharmaceuticals company in San Francisco, CA, filed 44 Form D notices with the SEC between 2013 and 2026. The latest, on July 1, 2026, reports $2 million sold of a $2 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 Pine St., Ste 400, San Francisco, CA, 94104
- Phone
- (415) 371-8300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1585608
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | New notice | $2,000,000 | $2,000,000 | 2 | Jun 9, 2026 | sec.gov | |
| Jul 1, 2026 | New notice | $40,800,000 | $40,800,000 | 1 | Jun 9, 2026 | sec.gov | |
| Nov 24, 2025 | New notice | $10,810,000 | $10,810,000 | 0 | Nov 12, 2025 | sec.gov | |
| Oct 10, 2025 | New notice | $1,000,000 | $1,000,000 | 1 | Sep 28, 2025 | sec.gov | |
| Sep 23, 2025 | New notice | $2,377,000 | $2,377,000 | 15 | Sep 10, 2025 | sec.gov | |
| May 28, 2025 | New notice | $1,500,003 | $1,500,003 | 3 | May 20, 2025 | sec.gov | |
| Nov 30, 2023 | New notice | $60,000 | $60,000 | 1 | Sep 1, 2023 | sec.gov | |
| May 11, 2023 | New notice | $1,832,304 | $1,832,304 | 3 | May 8, 2023 | sec.gov | |
| May 11, 2023 | New notice | $1,857,453 | $1,857,453 | 6 | May 8, 2023 | sec.gov | |
| Sep 23, 2022 | New notice | $7,140 | $7,140 | 1 | Sep 23, 2022 | sec.gov | |
| Sep 2, 2022 | New notice | $12,000,000 | $12,000,000 | 1 | Aug 24, 2022 | sec.gov | |
| Jul 8, 2022 | New notice | $10,000,000 | $300,000 | $9,700,000 | 1 | Jun 28, 2022 | sec.gov |
| Apr 26, 2022 | New notice | $50,820 | $50,820 | 1 | Sep 1, 2021 | sec.gov | |
| Apr 25, 2022 | New notice | $7,572 | $7,572 | 1 | Mar 7, 2022 | sec.gov | |
| Apr 25, 2022 | New notice | $39,800 | $39,800 | 1 | Apr 5, 2021 | sec.gov | |
| Sep 24, 2021 | New notice | $776,197 | $776,197 | 4 | Sep 13, 2021 | sec.gov | |
| Mar 26, 2021 | New notice | $10,000,000 | $10,000,000 | 1 | Mar 8, 2021 | sec.gov | |
| Feb 4, 2021 | New notice | $12,000,000 | $12,000,000 | 1 | Dec 22, 2020 | sec.gov | |
| Feb 4, 2021 | New notice | $6,220,812 | $6,220,812 | 1 | Jan 19, 2021 | sec.gov | |
| Sep 17, 2020 | New notice | $1,087,500 | $1,087,500 | 1 | Sep 1, 2020 | sec.gov | |
| Jun 5, 2020 | New notice | $4,447,779 | $4,447,779 | 11 | May 21, 2020 | sec.gov | |
| Apr 8, 2020 | New notice | $720,000 | $720,000 | 6 | Mar 23, 2020 | sec.gov | |
| Apr 7, 2020 | New notice | $2,030,000 | $2,030,000 | 1 | Mar 24, 2020 | sec.gov | |
| Jan 6, 2020 | New notice | $1,500,000 | $1,500,000 | 8 | Dec 24, 2019 | sec.gov | |
| Apr 3, 2019 | New notice | $12,100,000 | $800,000 | $11,300,000 | 2 | Mar 18, 2019 | sec.gov |
| Sep 27, 2018 | New notice | $774,844 | $774,844 | 2 | Sep 11, 2018 | sec.gov | |
| Sep 24, 2018 | New notice | $569,998 | $569,998 | 1 | Aug 28, 2018 | sec.gov | |
| Apr 2, 2018 | New notice | $7,000,000 | $4,999,999 | $2,000,001 | 4 | Mar 23, 2018 | sec.gov |
| Apr 2, 2018 | New notice | $2,240,909 | $2,240,909 | 1 | Mar 26, 2018 | sec.gov | |
| Apr 2, 2018 | New notice | $1,090,340 | $1,090,340 | 1 | Mar 21, 2018 | sec.gov | |
| Apr 2, 2018 | New notice | $9,199,001 | $9,199,001 | 1 | Mar 23, 2018 | sec.gov | |
| Mar 30, 2018 | New notice | $2,155,000 | $2,155,000 | 1 | Jun 29, 2017 | sec.gov | |
| Mar 30, 2018 | New notice | $1,587,500 | $1,587,500 | 11 | Dec 8, 2017 | sec.gov | |
| Jan 11, 2018 | New notice | $1,970,000 | $801,100 | $1,168,900 | 6 | Dec 27, 2017 | sec.gov |
| Aug 30, 2017 | New notice | $44,796,553 | $44,796,553 | 10 | Jul 31, 2017 | sec.gov | |
| Apr 2, 2015 | New notice | $1,500,000 | $1,000,000 | $500,000 | 1 | Mar 20, 2015 | sec.gov |
| Mar 9, 2015 | New notice | $4,000,000 | $900,000 | $3,100,000 | 5 | Dec 23, 2014 | sec.gov |
| Mar 6, 2015 | New notice | $1,000,000 | $1,000,000 | 2 | Dec 3, 2014 | sec.gov | |
| Sep 12, 2014 | New notice | $1,112,500 | $1,112,500 | 1 | Aug 26, 2014 | sec.gov | |
| Jun 16, 2014 | New notice | $300,000 | $300,000 | 2 | Jun 2, 2014 | sec.gov | |
| Jun 4, 2014 | Amendment | $1,300,000 | $525,000 | $775,000 | 4 | Jul 8, 2013 | sec.gov |
| May 7, 2014 | Amendment | $6,780,900 | $6,777,338 | $3,562 | 9 | Feb 5, 2014 | sec.gov |
| Feb 10, 2014 | New notice | $6,500,000 | $2,000,000 | $4,500,000 | 1 | Feb 5, 2014 | sec.gov |
| Sep 5, 2013 | New notice | $600,000 | $200,000 | $400,000 | 2 | Jul 8, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lisa Conte | Executive Officer, Director | |
| Carol Lizak | Executive Officer | |
| Steven King | Executive Officer | |
| Jonathan Wolin | Executive Officer | |
| James Bochnowski | Director | |
| John Micek III | Director | |
| Anula Jayasuriya | Director | |
| Jonathan Siegel | Director | |
| Pravin Chaturvedi | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jun 29, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Jaguar Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.